| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/10/2009 | US20090227536 Compositions comprising pectin and ascorbic acid |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227519 Compounds for control of appetite |
| 09/10/2009 | US20090227505 Methods and uses for protein breakdown products |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226553 Method and composition using irvingia gabonensis for reducing body weight |
| 09/10/2009 | US20090226546 Compositions derived from portulaca oleracea l. and methods of using same for modulating blood glucose levels |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226518 (monitoring only) combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hypelipidemia once a day at night |
| 09/10/2009 | US20090226510 Pharmaceutical compositions of atorvastatin |
| 09/10/2009 | US20090226437 Humanized anti-beta7 antagonists and uses therefor |
| 09/10/2009 | US20090226431 Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226392 Phosphate-Binding Polymers for Oral Administration |
| 09/10/2009 | DE102008003467A1 Flavonoide als Mittel zur Prophylaxe und Behandlung von neurodegenerativen und anderen Proteinfehlfaltungskrankheiten Flavonoids as a means for the prophylaxis and treatment of neurodegenerative diseases and other protein misfolding |
| 09/09/2009 | EP2098598A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 09/09/2009 | EP2098517A1 Novel phenyl-isoxazol-3-ol derivative |
| 09/09/2009 | EP2098515A1 Substituted carbinol compound |
| 09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP2098509A1 1-naphthyl alkylpiperidine derivative |
| 09/09/2009 | EP2098242A1 MCH derived peptide-containing food intake regulator |
| 09/09/2009 | EP2098241A1 Method for preventative treatment of health problems in calving cows |
| 09/09/2009 | EP2098239A1 Food intake regulator |
| 09/09/2009 | EP2098222A1 Physiologically active substance-containing granular composition and method of producing the same |
| 09/09/2009 | EP2097411A1 3 -amino-imidazo [1,2 -a]pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes |
| 09/09/2009 | EP2097409A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 09/09/2009 | EP2097391A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 09/09/2009 | EP2097388A1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| 09/09/2009 | EP2097380A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 09/09/2009 | EP2097373A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 09/09/2009 | EP2097371A2 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 09/09/2009 | EP2097138A2 Assay |
| 09/09/2009 | EP2097080A2 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 09/09/2009 | EP2097079A2 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 09/09/2009 | EP2096941A1 Nutritional composition |
| 09/09/2009 | EP1881958B1 Diacylglycerol acyltransferase inhibitors |
| 09/09/2009 | EP1838677B1 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 09/09/2009 | EP1833473B1 5ht2c receptor modulator compositions and methods of use |
| 09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP1610779B1 3-oxo-1,3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1478401B1 Compositions comprising dietary fat complexer and methods for their use |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | EP1098962B1 Diacylglycerol acyl transferase proteins |
| 09/09/2009 | CN101525390A Kappa-carrageenin oligose selenizing derivate, preparation method thereof and application for being used as medicine |
| 09/09/2009 | CN101525386A Fusion protein of Exendin-4 tandem polypeptide and human serum albumin, preparation and application thereof |
| 09/09/2009 | CN101525382A Method of purifying pramlintide |
| 09/09/2009 | CN101525366A 3-(2-carboxylbenzoyl)-oleanolic acid, pharmaceutical composition of same and application of same in treating diabetes and/or obesity |
| 09/09/2009 | CN101524530A The treatment of diabetes |
| 09/09/2009 | CN101524502A Chinese medicinal composition for treating blood lipid reduction |
| 09/09/2009 | CN101524496A Stomachic and digestive calcium granules or tablets |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524488A Preparation method of compound bamboo leave flavone dripping pill |
| 09/09/2009 | CN101524475A Sheep ossein tendon-and-bone strengthening calcium for preventing fatigue and tonifying kidney |
| 09/09/2009 | CN101524474A Deer bone ossein tendon-and-bone strengthening calcium for tonifying kidney, promoting vital essence and blood generation |
| 09/09/2009 | CN101524471A Pharmaceutical composition for treating diabetes and preparation method thereof |
| 09/09/2009 | CN101524456A Technology for producing antidiabetic drug |
| 09/09/2009 | CN101524454A Preparation process for Chinese yam extract |
| 09/09/2009 | CN101524441A Chinese medicinal composition for lipid-lowering and weight-losing and preparation method thereof |
| 09/09/2009 | CN101524422A Health products with hypolipemic function, preparation method and usage thereof |
| 09/09/2009 | CN101524419A Chinese medicinal composition for treating diabetes mellitus and preparation process thereof |
| 09/09/2009 | CN101524393A Preparation method of gypenoside |
| 09/09/2009 | CN101524377A Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
| 09/09/2009 | CN101524376A Extrusion wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524375A Wet-process wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524371A Snail egg nutrient solution and preparing method thereof |
| 09/09/2009 | CN101524331A Polysaccharide-liposome and preparation method and purpose thereof |
| 09/09/2009 | CN101524228A Production method of silk quilt for treating diabetes |
| 09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
| 09/09/2009 | CN101524140A Application of vanadium-rich eggs and method for producing same |
| 09/09/2009 | CN100537574C Preventive or therapeutic agent for diabetic maculopathy |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
| 09/09/2009 | CN100536863C Soybean saponin-containing material and process for producing the same |
| 09/09/2009 | CN100536858C Substances extracted from dictyotales, Preparation method therefor, and compositions containing same |
| 09/09/2009 | CN100536857C Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug |
| 09/09/2009 | CN100536846C Compositions comprising HMG-CoA reductase inhibitor |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | US7585835 GASP1: a follistatin domain containing protein |
| 09/08/2009 | US7585623 Syndrome X, metabolic syndrome, multiple risk factor syndrome, insulin resistant syndrome, deadly quartet, and visceral fat syndrome, diabetes, obesity, hypercholesterolemia, and hyperlipoproteinemias, hyperlipidemia, arteriosclerosis, hypertonia, circulatory system disease, hyperphagia |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2519919C Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2009 | CA2434482C Food supplement with a slimming effect |
| 09/08/2009 | CA2384422C Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 09/08/2009 | CA2353865C Therapeutic agents for hyperammonemia |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2261799C Composition comprising insulin and insulin-like growth factor-i (igf-i) |